Please login to the form below

Lucid Group has four programmes shortlisted for PMEA 2019

Lucid is celebrating four of their programmes being shortlisted in four categories at this year's PMEAs

Lucid’s talent for partnering with its clients to create magical healthcare communications is evident as they celebrate four of their programmes making the PMEA 2019 finals.

Jan Steele, Lucid Group COO and Co-founder commented, “2019 has been a transformative year for Lucid Group. We have gone through two acquisitions, allowing us to increase capability and reach. With all this change, it is a testament to our team’s dedication and passion that they continue to deliver outstanding work for our clients. I do not doubt that as we move into 2020 we will continue this incredible momentum with our work helping to transform more lives than ever before.”

PMEA recognises the achievements of responsible customer-centric business practices that provide patients with meaningful outcomes. The winners will be announced on Wednesday 27 November 2019 at the Royal Lancaster London.

More details about the shortlisted programmes can be found below:

Category: Excellence in Healthcare Professional Education and Support Programmes:   
CLEAR HORIZONS: A new era of psoriasis care
INSPIRE: Improving outcomes in paediatric cardiology

Category: Excellence in Capability Development
Global Medical Affairs as CATALYSTs for change

Category: Excellence in Innovation
DermDialogue: Bringing innovation to MSL‐led education

Excellence in Rare Diseases and Orphan Drugs
INSPIRE: Improving outcomes in paediatric cardiology

2nd October 2019



Company Details

Lucid Group Communications Limited

0345 0536671

Contact Website

First Floor, Jubilee House
Third Avenue
Globe Park

Latest content on this profile

My Lucid journey from PMW to Head of Medical
Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced and demanding industry, but one which offers enviable flexibility, variety and intellectual challenge. Leading agency Lucid Group prides itself on the many growth and development opportunities it offers its people. In this article, Katherine Duxbury, Lucid’s Head of Medical, reflects upon her own bespoke working journey over the past 12 years and explains how creativity, collaboration and a passion for science have led to a rewarding, stimulating and self-curated career.
Lucid Group Communications Limited
Listen, learn and lift off

Lucid Group Communications Limited
Launch excellence

Lucid Group Communications Limited
Meet The Lucid Group Talent Team
Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your career to the next level with us, you can be assured that you'll have a whole group of people here cheering you on.So, if you’re feeling stuck or unfulfilled in your current role and looking for a company that will provide the personal and career development you need, please check out our open roles here: contact one of our talent acquisition managers for a chat:Ellen Field Assoc CIPDElaine DowneyJon TurnerDaniel Newbury
Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)

Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)
In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so important?Because 300 million people worldwide are living with a rare disease. This means that, collectively, the number of people living with a rare disease is equivalent to the population of the world's third-largest country (USA).While we have come a long way since the inception of Rare Disease Day, there's still plenty of work to do.Part 2 of this series focuses on important topics including the role of technology and the opportunities it presents for the rare disease community. The panel also hold captivating insights on how the pandemic has impacted the use of related digital technologies, the role of gene therapy, the major challenges and successes for pharma companies in supporting the rare disease community over the last 13 years, and much, much more.If you’d like to know more about the work we do in rare diseases or would like advice on any healthcare communication challenges please get in touch with Clare Reynolds on LinkedIn or by email: clare.reynolds@wearelucidgroup.comAbout Lucid GroupFounded in 2007, Lucid Group is a global multi-capability healthcare consultancy with core expertise in medical strategy, healthcare communications, creative and brand strategy, motion, digital and technology, behaviour change, metrics, and data analytics.  We partner with the pharma and biotech industry, delivering life-transforming value with connected capabilities to create pioneering solutions that change behaviour, improve clinical practice and advance health outcomes.  Transforming lives. Always.
Lucid Group Communications Limited